Transcriptome sequencing of small cell lung cancer (SCLC) CDX revealed that the MYC signature negatively correlates with sensitivity to etoposide and platinum-based chemotherapy [128,129]. The gene discussed is MYC; the disease is small cell lung carcinoma.